Case dropped for 4th executive of firm


Federal prosecutors dropped fraud charges yesterday against a fourth executive of the pharmaceutical company Stryker Biotech, effectively closing a high-profile felony case against representatives of the Hopkinton-based company. Mark Philip, the former president of Stryker, and three former sales managers were accused of committing fraud against surgeons by promoting medical devices beyond their approved use. But just as a trial for the managers began, prosecutors dropped all charges after apparently concluding that no fraud had occurred. Philip’s case had been separated from the others because of a legal technicality, and charges against him were dropped yesterday.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of